ASCO15: VBL Therapeutics Reports Updated Interim Results From Phase II Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm)

Press/Media: Press / Media

PeriodJun 1 2015

Media coverage

2

Media coverage

  • TitleASCO15: VBL Therapeutics Reports Updated Interim Results From Phase II Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm)
    Media name/outletBioSpace
    CountryUnited States
    Date6/1/15
    PersonsAndrew Brenner
  • TitleASCO15: VBL Therapeutics (VBLX) Reports Updated Interim Results From Phase II Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm) 6/1/2015
    Media name/outletClinicSpace
    CountryCanada
    Date6/1/15
    PersonsAndrew Brenner